TD Cowen Maintains Buy on GeneDx Hldgs, Raises Price Target to $118

Benzinga · 01/07 16:57
TD Cowen analyst Dan Brennan maintains GeneDx Hldgs (NASDAQ:WGS) with a Buy and raises the price target from $75 to $118.